Evidence map›Paper›PMID 31973076›Full record

ReviewPlants (Basel, Switzerland)2020

Transgenesis as a Tool for the Efficient Production of Selected Secondary Metabolites from in Vitro Plant Cultures.

Tomasz Kowalczyk, Joanna Wieczfinska, Ewa Skała, Tomasz Śliwiński, Przemysław Sitarek

Open access · goldAbstract readReview
In one paragraph

Review in Plants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Raspberry Ketone Accumulation inJournal of agricultural and food chemistry · 2023
    Article
  7. Review
  8. Article
  9. Review
  10. Different Fruit-Specific Promoters DriveMolecules (Basel, Switzerland) · 2022
    Article
  11. Plants (Basel, Switzerland) · 2021
    Article
  12. Micropropagation of RareMolecules (Basel, Switzerland) · 2021
    Article
  13. Review
  14. Polyphenol RichMolecules (Basel, Switzerland) · 2021
    Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Tomasz KowalczykDepartment of Molecular Biotechnology and Genetics, University of Lodz, Banacha 12/16, 90-237, Lodz, Poland.
Joanna WieczfinskaDepartment of Immunopathology, Medical University of Lodz, 90-752, Żeligowskiego 7/9, Lodz, Poland.
Ewa SkałaDepartment of Biology and Pharmaceutical Botany, Medical University of Lodz, Muszynskiego 1, 90-151, Lodz, Poland.
Tomasz ŚliwińskiLaboratory of Medical Genetics, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.
Przemysław SitarekDepartment of Biology and Pharmaceutical Botany, Medical University of Lodz, Muszynskiego 1, 90-151, Lodz, Poland.
Medical University of Lodz · PLUniversity of Łódź · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The plant kingdom abounds in countless species with potential medical uses. Many of them contain valuable secondary metabolites belonging to different classes and demonstrating anticancer, anti-inflammatory, antioxidant, antimicrobial or antidiabetic properties. Many of these metabolites, e.g., paclitaxel, vinblastine, betulinic acid, chlorogenic acid or ferrulic acid, have potential applications in medicine. Additionally, these compounds have many therapeutic and health-promoting properties. The growing demand for these plant secondary metabolites forces the use of new green biotechnology tools to create new, more productive in vitro transgenic plant cultures. These procedures have yielded many promising results, and transgenic cultures have been found to be safe, efficient and cost-effective sources of valuable secondary metabolites for medicine and industry. This review focuses on the use of various in vitro plant culture systems for the production of secondary metabolites.

Indexed as

binary vectorsin vitro plant culturesmetabolic engineeringsecondary metabolitestransgenesistransgenic plants

Identifiers

PMID31973076
PMCPMC7076688
OpenAlexW3002363560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.